written on 28.05.2014

Valeant offloads aesthetic treatments to Nestlé's derm unit in $1.4B deal


Valeant CEO J. Michael Pearson is an aggressive buyer, especially when it comes to the fast-growing skincare field. But Pearson was also a seller Wednesday, shipping off rights to a handful of cosmetic products to Nestlé as the Swiss food group looks to expand into the dermatology space.